Fluticasone clinical trials
Also written Flovent, Flonase, OPN-375 and Flixotide.
Includes 105 studies of Fluticasone furoate.
Counted the way a researcher would: Fluticasone with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses Fluticasone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Fluticasone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 14 Dec 1990 · CUTIVATE · NDA 019957 (FDA, Drugs@FDA)
- European Union
- 11 Jan 2008 · Avamys · EMEA/H/C/000770 (EMA; as fluticasone furoate)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
In one entry with another drug
Given together, or one or the other
Studies by the year they started
336 studies that test it; most in 2007 (32); 1 more planned to start later
| Year | Studies |
|---|---|
| 1999 | 2 |
| 2000 | 1 |
| 2002 | 6 |
| 2003 | 8 |
| 2004 | 13 |
| 2005 | 26 |
| 2006 | 15 |
| 2007 | 32 |
| 2008 | 17 |
| 2009 | 20 |
| 2010 | 17 |
| 2011 | 20 |
| 2012 | 22 |
| 2013 | 19 |
| 2014 | 19 |
| 2015 | 14 |
| 2016 | 12 |
| 2017 | 8 |
| 2018 | 15 |
| 2019 | 9 |
| 2020 | 6 |
| 2021 | 11 |
| 2022 | 6 |
| 2023 | 10 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 225 · Other 115
GlaxoSmithKline (126) · Respirent Pharmaceuticals Co Ltd. (18) · Optinose US Inc. (10) · Teva Branded Pharmaceutical Products R&D, Inc. (10) · University of Chicago (8) · University of Dundee (6) · Dey (5) · Meda Pharmaceuticals (4)
Often tested with
Tested in the same studies.
Salmeterol Xinafoate (56) · Vilanterol (33) · GSK573719 (15) · Formoterol (13) · Budesonide (11) · Azelastine (11) · Montelukast (9) · Tiotropium (8)
Related medicines
As reviewed, each with the page that says it.
- One of Corticosteroids source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 5, 1 in phase 3
Studies that test Fluticasone, phase 3 first.
- Jan 2027A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With AsthmaPhase 3 · GlaxoSmithKline
- Dec 2026A Study to Visualize Multi-Symptom Allergy in Adults With Seasonal Allergic RhinitisPhase 4 · HALEON
- Jun 2027Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)Phase 2 · Cedars-Sinai Medical Center
- Sep 2027Novel Method for Removal of Orally Deposited Inhaled Fluticasone PropionatePhase 4 · University of Wisconsin, Madison
- Sep 2027129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of ExacerbationPhase 4 · Western University, Canada
Studies
Open first, then newest update. How each study uses Fluticasone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 340
- Novel Method for Removal of Orally Deposited Inhaled Fluticasone PropionateNot yet recruitingPhase 4University of Wisconsin, MadisonNCT07664527Written as Fluticasone Propionate
- Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)Not yet recruitingPhase 3Eurofarma Laboratorios S.A.NCT06234345Written as Fluticasone 250mcg/Formoterol 12mcg/Glycopyrronium 25mcg
- Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal PolypsRecruitingPhase 3Optinose US Inc.NCT06850805Written as OPN-375
- A Study to Visualize Multi-Symptom Allergy in Adults With Seasonal Allergic RhinitisNot yet recruitingPhase 4HALEONNCT07817134Written as Fluticasone propionate
- 129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of ExacerbationRecruitingPhase 4Western University, CanadaNCT07192016Written as fluticasone furoate(FF)/umeclidinium (UMEC)/vilanterol(VI) (100/62.5/25) mcg
- Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)RecruitingPhase 2Cedars-Sinai Medical CenterNCT05275686Written as Fluticasone Propionate 93 MCG/1 ACTUATION Nasal Spray
- U-LABA/ICS Effects on Exercise Performance, VilanterolRecruitingNot applicableMorten Hostrup, PhDNCT06066606Written as Vilanterol and Fluticasone Furoate (low dose)
- Role of Lung Function for Exercise Capacity in Well-trained IndividualsRecruitingNot applicableMorten Hostrup, PhDNCT06077019Written as Vilanterol and Fluticasone Furoate
- Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoERecruitingPhase 2University of Colorado, DenverNCT06705387Written as Fluticasone
- Effect of the Inhaled Triple Therapies Over the Small Airway in Biomass ExposureRecruitingPhase 4National Institute of Respiratory Diseases, MexicoNCT06571942Written as Fluthicasone / Vilanterol / Umeclidinium (100/25/62.5 mcg)
- Bioequivalence Study for Fluticasone Propionate 500 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy VolunteersRecruitingPhase 1Respirent Pharmaceuticals Co Ltd.NCT06025214Written as Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
- A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With AsthmaActive, not recruitingPhase 3GlaxoSmithKlineNCT05757102Written as FF/UMEC/VI
- Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled AsthmaActive, not recruitingPhase 4GlaxoSmithKlineNCT06372496Written as Fluticasone furoate/umeclidinium bromide/vilanterol trifenatate
- OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal PolypsCompletedPhase 3Optinose US Inc.NCT03747458Written as OPN-375
- Sub-Sensitivity to Long-Acting Bronchodilators (LABA)CompletedNot applicableNational Jewish HealthNCT01117116Written as fluticasone propionate and salmeterol
- Crisaborole vs Fluticasone Propionate in Mild to Moderate Atopic DermatitisCompletedNot applicableNoura Abdelmoneim Mohammed ElseessyNCT07537751Written as Fluticasone propionate 0.05% topical cream
- A Bronchoscopy Study to Assess the Effects of Inhaled Corticosteroids on Adult Healthy VolunteersActive, not recruitingPhase 4University Hospitals, LeicesterNCT02476825Written as Fluticasone propionate
- Seal, Stopping Eczema and Allergy StudyActive, not recruitingPhase 2Kari Nadeau, MD, PhDNCT03742414Written as Fluticasone propionate Cream 0.05%
- INTRANASAL FLUTICASONE VERSUS FLUTICASONE-AZELASTINE COMBINATIONActive, not recruitingPhase 4Pamukkale UniversityNCT07415278Written as Fluticasone propionate nasal spray
- Comparative Effects of Triple Inhaled Therapy With Budesonide/Glycopyrronium/Formoterol Versus Fluticasone Furoate/Umeclidinium/Vilanterol on Small Airway Disease in COPD Patients: A Randomized Crossover StudyCompletedPhase 4Thammasat UniversityNCT06905483Written as Fluticasone Furoate/Umeclidinium/Vilanterol (FUV)
See all 340 studies that test Fluticasone →
Given beside what is tested · 56 — Fluticasone is usual care or a partner of the new treatment
- A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.RecruitingPhase 3Novartis PharmaceuticalsNCT05776927Written as Salmeterol Xinafoate / Fluticasone Propionate
- BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)RecruitingPhase 2Dana-Farber Cancer InstituteNCT05922761Written as Fluticasone
- Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk AsthmaActive, not recruitingPhase 2SanofiNCT06676319Written as Fluticasone/Salmeterol
- Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years OldCompletedPhase 1Teva Branded Pharmaceutical Products R&D, Inc.NCT06290102Written as Fp MDPI
- Evaluation of the Adjunctive Effects of Moxibustion in the Treatment of Cold-Syndrome Allergic RhinitisActive, not recruitingNot applicableUniversity of Medicine and Pharmacy at Ho Chi Minh CityNCT07537439Written as Fluticasone propionate 100 mcg
- Using a Contact Dermatitis Model With Biologic Medications to Study Skin InflammationActive, not recruitingPhase 2/3Wei-Che KoNCT05535738Written as Fluticasone Propionate
- Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled AsthmaActive, not recruitingPhase 4Regeneron PharmaceuticalsNCT06572228Written as ICS/LABA
- Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)CompletedPhase 3Organon and CoNCT00127166Written as Fluticasone propionate
- Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With AsthmaCompletedPhase 2SanofiNCT02573233Written as fluticasone propionate and salmeterol
- Role of Montelukast in the Management of Chronic Rhinosinusitis With Nasal Polyps.Status unknownPhase 1/2Assiut UniversityNCT05143502Written as Fluticasone Furoate
- A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled AsthmaCompletedPhase 3GlaxoSmithKlineNCT02924688Written as Fluticasone/salmeterol (FSC)
- Hypertonic Versus Isotonic Saline Irrigations for Chronic RhinosinusitisWithdrawnPhase 2/3Stanford UniversityNCT04242368Written as Fluticasone Propionate
- Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With AsthmaCompletedPhase 2GlaxoSmithKlineNCT03012061Written as Fluticasone Furoate
- Perioperative Oral Steroids for Chronic Rhinosinusitis Without Polyps (CRSsNP)CompletedNot applicableStanford UniversityNCT02748070Written as Flonase
- Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe AsthmaCompletedPhase 2GlaxoSmithKlineNCT03207243Written as Fluticasone propionate/salmeterol
- Environmental Control as Add-on Therapy in Childhood AsthmaCompletedPhase 2Johns Hopkins UniversityNCT02251379Written as Flovent Diskus
- Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 3GlaxoSmithKlineNCT02729051Written as FF/UMEC/VI
- An Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in AsthmaCompletedPhase 3GlaxoSmithKlineNCT01706198Written as fluticasone furoate + vilanterol
- EoE RCT Fluticasone and Omeprazole vs Fluticasone AloneStatus unknownPhase 4Claire DanielsNCT03781596Written as Fluticasone
- Effect of Health Promotion on Allergic Rhinitis by Infrared-C Ray IrradiationCompletedNot applicableNanhua UniversityNCT03673384Written as Fluticasone Furoate
Showing 20 of 56.
As the comparator · 67 — what is tested is compared with Fluticasone
- A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With AsthmaCompletedPhase 3Teva Branded Pharmaceutical Products R&D LLCNCT06664619Written as FP
- Effects of the Direct Interaction Between Streptococcus Salivarius 24SMBc and Streptococcus Oralis 89a and the Respiratory Epithelium in ChildrenCompletedPhase 3Federico II UniversityNCT03449836Written as fluticasone + mometasone
- Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).TerminatedPhase 2Boehringer IngelheimNCT01396278Written as Fluticasone propionate
- Efficacy of Intermittent Tiotropium in Early Childhood WheezingTerminatedPhase 4Helsinki University Central HospitalNCT03199976Written as Fluticasone Propionate
- Elocon vs Fluticasone in Localized Psoriasis (P03197)CompletedPhase 4Organon and CoNCT00763529Written as Fluticasone
- Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418)CompletedPhase 4Organon and CoNCT00394355Written as fluticasone propionate hydrofluoroalkane (HFA)
- Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)CompletedPhase 3Organon and CoNCT00284856Written as Comparator: fluticasone
- Dose Finding Study on BI54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat® Inhaler in Asthmatic Patients Inadequately Controlled on Short-acting-beta-agonist (SABA) TherapyTerminatedPhase 2Boehringer IngelheimNCT01397162Written as Fluticasone propionate
- Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroid (ICS)TerminatedPhase 2Boehringer IngelheimNCT01397201Written as Fluticasone propionate
- BI 671800 ED in Steroid-naive Asthmatic PatientsCompletedPhase 2Boehringer IngelheimNCT01092143Written as Fluticasone propionate
- To Study Generic Fluticasone Propionate Inhalation Aerosol for the Treatment of Bronchial AsthmaStatus unknownPhase 3Glenmark Pharmaceuticals Ltd. IndiaNCT05363202Written as FLOVENT HFA 44 mcg
- A Study to Assess Efficacy and Safety of Nasacort® Nasal Spray in Comparison With Flixonase® Nasal Spray in Adults Suffering From Perennial Allergic Rhinitis (PAR)CompletedPhase 3SanofiNCT03317015Written as fluticasone
- DYmista NAsal Spray in CHInese PatientsCompletedPhase 3MEDA Pharma GmbH & Co. KGNCT03599791Written as Fluticasone Propionate 0.05 MG/ACTUAT
- A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)WithdrawnPhase 3Organon and CoNCT00540839Written as Fluticasone propionate
- A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512)CompletedPhase 3Organon and CoNCT00783224Written as Fluticasone
- Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001)CompletedPhase 3Organon and CoNCT03882047Written as Fluticasone propionate
- Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult PatientsTerminatedPhase 4Teva Branded Pharmaceutical Products R&D, Inc.NCT00071552Written as Flovent Diskus
- Lung Bioavailability and Total Systemic Exposure to Beclomethasone17MonoPropionate and Formoterol Across Two Strengths of NEXThaler Inhalation PowderCompletedPhase 2Chiesi Farmaceutici S.p.A.NCT01738087Written as Flixotide Accuhaler 500 mcg
- Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + TiotropiumCompletedPhase 3Novartis PharmaceuticalsNCT03158311Written as Salmeterol/fluticasone plus tiotropium
- Study to Analyse Difference in Bioavailability Between MP29-02 and Fluticasone PropionateWithdrawnNot applicableUniversity Hospital, GhentNCT02883439Written as Fluticasone propionate
Showing 20 of 67.
Codes
What other systems call Fluticasone · ClinicalTrials.gg INT006508
- MeSH (NLM) D000068298FluticasoneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) CUT2W21N7UFLUTICASONEConfirmed FDA, NLM, Wikidata
- RxNorm 41126Confirmed FDA, Wikidata
- Wikidata Q1002165fluticasoneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61767FluticasoneOne source FDA
- DrugBank DB13867One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000068298 | Fluticasone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | CUT2W21N7U | FLUTICASONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 41126 | — | Confirmed FDA, Wikidata |
| Wikidata | Q1002165 | fluticasone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61767 | Fluticasone | One source FDA |
| DrugBank | DB13867 | — | One source Wikidata |
Also registered as fluticasone propionate (UNII O2GMZ0LF5W · RxNorm 50121).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.